The FDA has authorized Moderna’s booster only for people ages 65 and older, adults at high risk of severe COVID-19 infection or adults whose jobs put them at a high risk of infection. However, several states and New York City have expanded booster eligibility to all adults ahead of FDA authorization.
Moderna noted in its announcement that its booster shot is already authorized for all adults in many international markets.
More than 71 million people in the U.S. have been fully vaccinated with Moderna’s COVID-19 vaccine, and more than 12 million have gotten a Moderna booster as of Nov. 16, according to CDC data.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.